Novavax: Large study finds COVID-19 shot about 90% effective

News

FILE – In this Wednesday, Oct. 7, 2020, file photo, a vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George’s University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant, File)

NEW YORK — Vaccine maker Novavax says its shot is highly effective against COVID-19 and also protects against variants.

The Maryland-based company on Monday announced results from a large, late-stage study in the U.S. and Mexico that found its vaccine was about 90% effective. Preliminary data also showed it was safe.

Novavax previously released results from smaller studies in Britain and South Africa. The company plans by the end of September to file for emergency use authorization in the U.S., Europe and elsewhere.

Novavax’s vaccine is made by growing harmless copies of the coronavirus spike protein in the laboratory.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trademark and Copyright 2021 The Associated Press. All rights reserved.

Are you vaccinated for COVID-19?

Yes
No, but I plan to get the vaccine
No, and I do not plan to get the vaccine


Created with Survey Maker

For people who are fully vaccinated, are you ditching the mask?

Yes!
No!
Will still use it sometimes


Created with Survey maker

Trending Stories

Latest News

More News

Watch Latest Videos

The world's best cornhole players land in Memphis for ACL Pro Series

Leaders speak at community walk through

'I didn’t mean to startle anyone': Bodycam footage shows arrest of Iowa man found with guns, ammo in hotel

Good Bones star teaches Fountain Square porch pirates a lesson with pranks

Bucks Psychic: Averill Park graduate predicted finals win in 2018 yearbook

More News